普米克令舒辅助治疗儿童支原体肺炎疗效观察

Curative Effect of Pulmicort in the Adjuvant Treatment of Mycoplasma Pneumonia in Children

目的:探究普米克令舒辅助治疗儿童支原体肺炎的疗效。方法:将某院2014年5月~2016年12月收治的120例支原体肺炎患儿随机分为观察组(n=60)和对照组(n=60),对照组采用阿奇霉素治疗,观察组在对照组基础上联合普米克令舒雾化吸入治疗,比较两组临床疗效、症状改善时间、住院时间及不良反应发生率。结果:观察组临床疗效总有效率(93.33%)显著高于对照组(75.00%)(P<0.05);观察组退热时间、咳嗽缓解时间、肺啰音消失时间及住院时间均显著早于对照组(P<0.05);观察组不良反应发生率(3.33%)显著低于对照组(15.00%)(P<0.05)。结论:阿奇霉素联合普米克令舒雾化吸入辅助治疗能有效改善支原体肺炎患儿临床症状,值得在临床上推广应用。

Objective:To explore the curative effect of pulmicort in the adjuvant treatment of mycoplasma pneumonia in children.Methods:120 cases of children with mycoplasma pneumonia treated in a hospital from May 2014 to December 2016 were randomly divided into the observation group(n=60)and the control group(n=60).The control group was treated with azithromycin,and the observation group was additionally treated with pulmicort.The curative effect,symptom improvement time,hospitalization time and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the observation group was significantly higher than that in the control group(93.33% vs 75.00%)(P<0.05).The fever clearance time,cough relieving time,lung rale disappearance time and the hospitalization time of the observation group were significantly earlier or shorter than those of the control group(P<0.05).The incidence of adverse reactions in the observation group(3.33%)was significantly lower than that in the control group(15.00%)(P<0.05).Conclusion:Azithromycin combined with pulmicort inhalation therapy can effectively improve the clinical symptoms in children with mycoplasma pneumonia,which is worthy of clinical promotion and application.